Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanmin Hu

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Antibiotics (Basel, Switzerland)|March 25, 2022
The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> in Clinical SettingsFrank Jones, Yanmin Hu, Anthony Coates
Tuberculosis (Edinburgh, Scotland)|March 13, 2012
Sudden cardiac death and tuberculosis - how much do we know?Alexander Liu, Yanmin Hu, Anthony Coates
Trends in Pharmacological Sciences|February 12, 2008
Targeting non-multiplying organisms as a way to develop novel antimicrobialsAnthony R M Coates, Yanmin Hu
Drugs in R&D|June 7, 2006
New strategies for antibacterial drug design: targeting non-multiplying latent bacteriaAnthony R M Coates, Yanmin Hu
Plos One|April 3, 2009
Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpXYanmin Hu, Anthony R M Coates
British Journal of Pharmacology|February 18, 2011
Novel classes of antibiotics or more of the same?Anthony R M Coates, Gerry Halls, Yanmin Hu
Nature Reviews. Drug Discovery|November 5, 2002
The future challenges facing the development of new antimicrobial drugsAnthony Coates, Yanmin Hu, Richard Bax, et al.
International Journal of Cardiology|October 2, 2012
Tuberculous endocarditisAlexander Liu, Edward Nicol, Yanmin Hu, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
A Novel erm(44) Gene Variant from a Human Staphylococcus saprophyticus Isolate Confers Resistance to Macrolides and Lincosamides but Not StreptograminsChristian Strauss, Yanmin Hu, Anthony Coates, et al.
Novartis Foundation Symposium|June 26, 2008
Chaperonin 60 and macrophage activationAnthony R M Coates, Ana Cehovin, Yanmin Hu
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Antibiotics (Basel, Switzerland)|March 25, 2022
The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> in Clinical SettingsFrank Jones, Yanmin Hu, Anthony Coates
Tuberculosis (Edinburgh, Scotland)|March 13, 2012
Sudden cardiac death and tuberculosis - how much do we know?Alexander Liu, Yanmin Hu, Anthony Coates
Trends in Pharmacological Sciences|February 12, 2008
Targeting non-multiplying organisms as a way to develop novel antimicrobialsAnthony R M Coates, Yanmin Hu
Drugs in R&D|June 7, 2006
New strategies for antibacterial drug design: targeting non-multiplying latent bacteriaAnthony R M Coates, Yanmin Hu
Plos One|April 3, 2009
Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpXYanmin Hu, Anthony R M Coates
British Journal of Pharmacology|February 18, 2011
Novel classes of antibiotics or more of the same?Anthony R M Coates, Gerry Halls, Yanmin Hu
Nature Reviews. Drug Discovery|November 5, 2002
The future challenges facing the development of new antimicrobial drugsAnthony Coates, Yanmin Hu, Richard Bax, et al.
International Journal of Cardiology|October 2, 2012
Tuberculous endocarditisAlexander Liu, Edward Nicol, Yanmin Hu, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
A Novel erm(44) Gene Variant from a Human Staphylococcus saprophyticus Isolate Confers Resistance to Macrolides and Lincosamides but Not StreptograminsChristian Strauss, Yanmin Hu, Anthony Coates, et al.
Novartis Foundation Symposium|June 26, 2008
Chaperonin 60 and macrophage activationAnthony R M Coates, Ana Cehovin, Yanmin Hu
Pageof 8